The Technical Analyst
Select Language :
Biovie Inc [BIVI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Biovie Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Biovie Inc is listed at the  Exchange

-0.94% $0.529

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 29.03 mill
EPS: -1.170
P/E: -0.450
Earnings Date: May 07, 2024
SharesOutstanding: 54.92 mill
Avg Daily Volume: 2.51 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.450 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.08x
Company: PE -0.450 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.155
(-70.64%) $-0.373
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.286 - 0.772

( +/- 45.97%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-04 Do Cuong V Buy 10 000 Common stock
2024-03-04 Do Cuong V Buy 5 000 Warrants (right to buy)
2023-12-11 Kim Joanne Wendy Buy 5 000 Common Stock
2023-11-09 Lang James Paul Buy 93 500 Stock Option (right to buy)
2023-11-09 Gorlin Steve Buy 46 358 Common Stock
INSIDER POWER
92.55
Last 94 transactions
Buy: 39 235 676 | Sell: 4 917 434

Forecast: 16:00 - $0.526

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.526
Forecast 2: 16:00 - $0.526
Forecast 3: 16:00 - $0.526
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.529 (-0.94% )
Volume 0.774 mill
Avg. Vol. 2.51 mill
% of Avg. Vol 30.88 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Biovie Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Biovie Inc

RSI

Intraday RSI14 chart for Biovie Inc

Last 10 Buy & Sell Signals For BIVI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Biovie Inc

BIVI

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.

Last 10 Buy Signals

Date Signal @
RSS3USDMar 28 - 19:220.561
GHSTUSDMar 28 - 19:24$1.547
OSHIUSDMar 28 - 19:1983.11
ERNUSDMar 28 - 19:19$6.33
USDTUSDMar 28 - 19:17$1.000
KUBUSDMar 28 - 19:082.69
FISUSDMar 28 - 19:030.952
PROPCUSDMar 28 - 18:585.09
XCADUSDMar 28 - 18:571.490
INDEXUSDMar 28 - 18:565.95

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.